Publications found:
73,128
Sort by:
Leber Congenital Amaurosis (LCA) - Pipeline Review, H2 2020
US$ 2,000.00
... . The Leber Congenital Amaurosis (LCA) (Genetic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Leber Congenital Amaurosis (LCA) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
September 2020
80 pages
Neuromyelitis Optica (Devic’s Syndrome) - Pipeline Review, H2 2020
US$ 2,000.00
... . The Neuromyelitis Optica (Devic’s Syndrome) (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Neuromyelitis Optica (Devic’s Syndrome) and features dormant and discontinued projects. The guide covers therapeutics under Development ...
September 2020
163 pages
Uveal Melanoma - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Uveal Melanoma (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Uveal Melanoma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
September 2020
331 pages
Alcoholic Hepatitis - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Alcoholic Hepatitis (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Alcoholic Hepatitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
September 2020
103 pages
Hand, Foot and Mouth Disease - Pipeline Review, H2 2020
US$ 2,000.00
... . The Hand, Foot and Mouth Disease (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Hand, Foot and Mouth Disease and features dormant and discontinued projects. The guide covers therapeutics under Development ...
September 2020
43 pages
Resistant Pseudomonas aeruginosa Infections - Pipeline Review, H2 2020
US$ 2,000.00
... . The Resistant Pseudomonas aeruginosa Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Resistant Pseudomonas aeruginosa Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
September 2020
57 pages
Liver Transplant Rejection - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Liver Transplant Rejection (Immunology) pipeline guide also reviews of key players involved in therapeutic development for Liver Transplant Rejection and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
September 2020
73 pages
Lassa Fever (Lassa Hemorrhagic Fever) - Pipeline Review, H2 2020
US$ 2,000.00
... . The Lassa Fever (Lassa Hemorrhagic Fever) (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Lassa Fever (Lassa Hemorrhagic Fever) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
September 2020
70 pages
Achondroplasia - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Achondroplasia (Musculoskeletal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Achondroplasia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
September 2020
66 pages
Automated Liquid Handling Market By Type (Standalone, Individual Benchtop Workstation, Multi-Instrument System, and Others), Modality (Fixed Tips and Disposable Tips), Procedure (PCR-Set-Up, Serial Dilution, High-Throughput Screening, Cell Culture, Whole Genome Amplification, Plate Reformatting, Array Printing, and Other Procedures), End User (Biotechnology & Pharmaceutical Companies, Contract Research Organizations, and Academic & Government Research institutes): Global Opportunity Analysis and Industry Forecast, 2020–2027
US$ 5,769.00
... high throughput analysis is crucial in such processes. Automated liquid handling offers high throughput processing at the expense of ... hamper the market growth. Furthermore, untapped potential of emerging markets provides lucrative opportunities to the market players. The automated liquid handling market is ...
September 2020
282 pages
Cancer Anorexia-Cachexia Syndrome - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Cancer Anorexia-Cachexia Syndrome (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Cancer Anorexia-Cachexia Syndrome and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
September 2020
102 pages
Drug Overdose - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Drug Overdose (Toxicology) pipeline guide also reviews of key players involved in therapeutic development for Drug Overdose and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
September 2020
79 pages
Epstein-Barr Virus (HHV-4) Infections - Pipeline Review, H2 2020
US$ 2,000.00
... . The Epstein-Barr Virus (HHV-4) Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Epstein-Barr Virus (HHV-4) Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
September 2020
209 pages
Hypopharyngeal Cancer - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Hypopharyngeal Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Hypopharyngeal Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
September 2020
495 pages
Influenza A Virus, H1N1 Subtype Infections - Pipeline Review, H2 2020
US$ 2,000.00
... . The Influenza A Virus, H1N1 Subtype Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Influenza A Virus, H1N1 Subtype Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
September 2020
270 pages
Influenza A Virus, H5N1 Subtype Infections - Pipeline Review, H2 2020
US$ 2,000.00
... . The Influenza A Virus, H5N1 Subtype Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Influenza A Virus, H5N1 Subtype Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
September 2020
192 pages
Influenzavirus B Infections - Pipeline Review, H2 2020
US$ 2,000.00
... . The Influenzavirus B Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Influenzavirus B Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
September 2020
182 pages
Malignant Pleural Effusion - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Malignant Pleural Effusion (Respiratory) pipeline guide also reviews of key players involved in therapeutic development for Malignant Pleural Effusion and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
September 2020
50 pages
Marburgvirus Infections (Marburg Hemorrhagic Fever) - Pipeline Review, H2 2020
US$ 2,000.00
... . The Marburgvirus Infections (Marburg Hemorrhagic Fever) (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Marburgvirus Infections (Marburg Hemorrhagic Fever) and features dormant and discontinued projects. The guide covers therapeutics under Development ...
September 2020
112 pages
Pseudomonas aeruginosa Pneumonia - Pipeline Review, H2 2020
US$ 2,000.00
... . The Pseudomonas aeruginosa Pneumonia (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Pseudomonas aeruginosa Pneumonia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
September 2020
35 pages
Heavy Metal Poisoning - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Heavy Metal Poisoning (Toxicology) pipeline guide also reviews of key players involved in therapeutic development for Heavy Metal Poisoning and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
September 2020
36 pages
Leber’s Hereditary Optic Neuropathy (Leber Optic Atrophy) - Pipeline Review, H2 2020
US$ 2,000.00
... Leber’s Hereditary Optic Neuropathy (Leber Optic Atrophy) (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Leber’s Hereditary Optic Neuropathy (Leber Optic Atrophy) and features dormant and discontinued projects. The guide covers therapeutics under Development ...
September 2020
119 pages
Digital Therapeutics Market by Application (Diabetes, Obesity, Cardiovascular Disease (CVD), Central Nervous System (CNS) Disease, Respiratory Disease, Smoking Cessation, Gastrointestinal Disorder (GID), and Others), Product Type (Software and Device), and Sales Channel (Business-to-Business (B2B), Business-to-Consumer (B2C)): Global Opportunity Analysis and Industry Forecast, 2020–2027
US$ 6,168.00
... the players operating in this market. The global digital therapeutics market is segmented into application, product, sales channel, and region. Based on application, the market is divided into diabetes ...
September 2020
280 pages
5-Hydroxytryptamine Receptor 2B - Pipeline Review, H2 2020
US$ 3,500.00
5-Hydroxytryptamine Receptor 2B - Pipeline Review, H2 2020 SUMMARY According to the recently published report '5-Hydroxytryptamine Receptor 2B - Pipeline Review, H2 2020'; 5-Hydroxytryptamine Receptor...
September 2020
49 pages
5-Hydroxytryptamine Receptor 7 - Pipeline Review, H2 2020
US$ 3,500.00
5-Hydroxytryptamine Receptor 7 - Pipeline Review, H2 2020 SUMMARY 5-Hydroxytryptamine Receptor 7 (5 HT7 or 5 HTX or Serotonin Receptor 7 or HTR7) pipeline Target constitutes close to 13 molecules. Out...
September 2020
76 pages
Aryl Hydrocarbon Receptor - Pipeline Review, H2 2020
US$ 3,500.00
Aryl Hydrocarbon Receptor - Pipeline Review, H2 2020 SUMMARY Aryl Hydrocarbon Receptor (Class E Basic Helix Loop Helix Protein 76 or bHLHe76 or AHR) pipeline Target constitutes close to 27 molecules....
September 2020
122 pages
C-C Chemokine Receptor Type 4 - Pipeline Review, H2 2020
US$ 3,500.00
C-C Chemokine Receptor Type 4 - Pipeline Review, H2 2020 SUMMARY C-C Chemokine Receptor Type 4 (K5-5 or CD194 or CCR4) pipeline Target constitutes close to 9 molecules. Out of which approximately 8 mo...
September 2020
55 pages
Heparanase - Pipeline Review, H2 2020
US$ 3,500.00
Heparanase - Pipeline Review, H2 2020 SUMMARY Heparanase (Endo Glucoronidase or Heparanase 1 or HPSE or EC 3.2.1.166) pipeline Target constitutes close to 12 molecules. Out of which approximately 10 m...
September 2020
58 pages
High Mobility Group Protein B1 - Pipeline Review, H2 2020
US$ 3,500.00
High Mobility Group Protein B1 - Pipeline Review, H2 2020 SUMMARY High Mobility Group Protein B1 (High Mobility Group Protein 1 or High Mobility Group Protein Box 1 or HMGB1) - High mobility group box...
September 2020
50 pages
Actinic (Solar) Keratosis - Pipeline Review, H2 2020
US$ 2,000.00
Actinic (Solar) Keratosis - Pipeline Review, H2 2020 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Actinic (Solar) Keratosis - Pipeline Review, H2 2020, p...
September 2020
69 pages
Calcitonin Gene Related Peptide - Pipeline Review, H2 2020
US$ 3,500.00
Calcitonin Gene Related Peptide - Pipeline Review, H2 2020 SUMMARY According to the recently published report 'Calcitonin Gene Related Peptide - Pipeline Review, H2 2020'; Calcitonin Gene Related Pept...
September 2020
96 pages
Cell Therapy Market by Cell Type (Stem Cell and Non-Stem Cell), Therapy Type (Autologous and Allogenic), Therapeutic Area (Malignancies, Musculoskeletal Disorders, Autoimmune Disorders, Dermatology, and Others), and End User (Hospitals & Clinics and Academic & Research Institutes): Global Opportunity Analysis and Industry Forecast, 2020–2027
US$ 5,769.00
The global cell therapy market accounted for $7,754.89 million in 2019, and is expected to reach $48,115.40 million by 2027, registering a CAGR of 25.6% from 2020 to 2027. Cell therapy involves admini...
September 2020
241 pages
COVID-19 Impact Analysis on Construction & Manufacturing Industry by Construction Industry (Building Construction, Transportation Infrastructure, Construction Materials, and Construction Services) and Manufacturing Industry (Packaging, Heating, Ventilation, and Air Conditioning (HVAC), Equipment and Machinery, and Manufacturing Services): Global Opportunity Analysis and Industry Forecast, 2020–2022
US$ 5,769.00
The global construction industry market size was $9,500.5 billion in 2019, and is expected to reach $9,771.9 billion by 2022. In addition, the global manufacturing industry market size was $4,923.5 bi...
September 2020
69 pages
Global Markets for Treatment and Diagnosis of Sexually Transmitted Diseases
US$ 5,500.00
... report includes an overview of the global market scenario for diagnosis and treatments of sexually transmitted disease with base year data of 2017, ... additional tables An overview of the global market for diagnosis and treatments of sexually transmitted diseases Country specific data and analysis for United ...
September 2020
163 pages
North America Liver Disease Treatment Market by Treatment Type (Antiviral Drugs, Immunosuppressants, Vaccines, Immunoglobulins, Corticosteroids, Targeted Therapy, and Chemotherapy) and Disease Type (Hepatitis, Autoimmune Diseases, Non-Alcoholic Fatty Liver Disease, Cancer, Genetic Disorders, and Others): Opportunity Analysis and Industry Forecast, 2020–2027
US$ 4,649.00
The North America liver disease treatment market accounted for $6,970 million in 2019, and is expected to reach $8,318 million by 2027, registering a CAGR of 5.2% from 2020 to 2027. Medical care given...
September 2020
137 pages
Global Anti Acne Makeup Market Report 2020
US$ 2,350.00
... maintained a relatively optimistic growth, the past four years, Anti Acne Makeup market size to maintain the average annual growth rate of XXX ... the next few years, Anti Acne Makeup market size will be further expanded, we expect that by 2022, The market size of the Anti Acne Makeup will reach XXX million ...
September 2020
118 pages
Global Dental Scanner Market Report 2020
US$ 2,350.00
... still maintained a relatively optimistic growth, the past four years, Dental Scanner market size to maintain the average annual growth rate of *% from ... the next few years, Dental Scanner market size will be further expanded, we expect that by 2022, The market size of the Dental Scanner will reach XXXX million ...
September 2020
118 pages
Global Bioresorbable Polymers Market Report 2020
US$ 2,350.00
... maintained a relatively optimistic growth, the past four years, Bioresorbable Polymers market size to maintain the average annual growth rate of ... next few years, Bioresorbable Polymers market size will be further expanded, we expect that by 2023, The market size of the Bioresorbable Polymers will reach XXX ...
September 2020
119 pages
Global Lanreotide Drugs Market Report 2020
US$ 2,350.00
... maintained a relatively optimistic growth, the past four years, Lanreotide Drugs market size to maintain the average annual growth rate of XXX ... the next few years, Lanreotide Drugs market size will be further expanded, we expect that by 2023, The market size of the Lanreotide Drugs will reach XXX million ...
September 2020
115 pages
Global Disintegrants Market Report 2020
US$ 2,350.00
... still maintained a relatively optimistic growth, the past four years, Disintegrants market size to maintain the average annual growth rate of XXX from ... $ in 2018, BisReport analysts believe that in the next few years, Disintegrants market size will be further expanded, we expect that by 2023, The ...
September 2020
123 pages
Global Glycosylated Hemoglobin C-peptide Market Report 2020
US$ 2,350.00
?Global Glycosylated Hemoglobin C-peptide Market Report 2020 Page: 115 Chart and Figure: 124 At the beginning of 2020, COVID-19 disease began to spread around the world, millions of people worldwide w...
September 2020
125 pages
Global Coronavirus Testing Kits Market Report 2020
US$ 2,350.00
?Global Coronavirus Testing Kits Market Report 2020 Page: 115 Chart and Figure: 124 At the beginning of 2020, COVID-19 disease began to spread around the world, millions of people worldwide were infec...
September 2020
121 pages
Global Insulin Glargine and Lispro Market Report 2020
US$ 2,350.00
?Global Insulin Glargine and Lispro Market Report 2020 Page: 115 Chart and Figure: 124 At the beginning of 2020, COVID-19 disease began to spread around the world, millions of people worldwide were in...
September 2020
124 pages
Global Adrenomyeloneuropathy Treatment Market Report 2020
US$ 2,350.00
?Global Adrenomyeloneuropathy Treatment Market Report 2020 Page: 115 Chart and Figure: 124 At the beginning of 2020, COVID-19 disease began to spread around the world, millions of people worldwide wer...
September 2020
119 pages
Global Agricultural Animal Insurance Market Report 2020
US$ 2,350.00
?Global Agricultural Animal Insurance Market Report 2020 Page: 115 Chart and Figure: 124 At the beginning of 2020, COVID-19 disease began to spread around the world, millions of people worldwide were...
September 2020
117 pages
